1. Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population.
- Author
-
Hu, Wen, Shao, Xiaojuan, Guo, Dianxuan, Hao, Hairong, Zhang, Yong, Xia, Mingfeng, Gong, Yingyun, Zhou, Hongwen, Fan, Yunqing, and Yu, Weinan
- Subjects
FATTY liver ,THERAPEUTICS ,BLOOD serum analysis ,DISEASE progression ,PUBLIC health ,PROGNOSIS - Abstract
Objective: This study aimed to investigate the association of serum betatrophin with the status and progression of nonalcoholic fatty liver disease (NAFLD). Methods: A total of 249 subjects who received ultrasonic examination of liver fat content (LFC) were recruited. Anthropometric and biochemical examinations were performed. Serum betatrophin was measured by ELISA. Results: Compared with control group, serum betatrophin significantly increased in NAFLD group (P < 0.05). There was significant difference in serum betatrophin among control, low liver fat content (LLFC), and high liver fat content (HLFC) groups (P < 0.01). After adjustment for gender, age, BMI, FPG and HbA1c, the betatrophin positively correlated with LFC (r = 0.185, P < 0.01) and TG (r = 0.195, P < 0.01). Stepwise multiple regression analysis indicated serum betatrophin was independently related to LFC (P < 0.05). Multivariate logistic regression analysis revealed subjects in the highest tertile of serum betatrophin had higher odds of having NAFLD after adjustment for traditional NAFLD risk factors (OR = 2.88, 95%CI: 1.15โ7.19) (P<0.05). Conclusion: Serum betatrophin is an independent risk factor for NAFLD and potential non-invasive marker for its progression. Serum betatrophin may be helpful for the early diagnosis of NAFLD and improvement of its prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF